Chiome Bioscience Inc. | Ownership
Companies that own Chiome Bioscience Inc.
Siemens Fonds Invest GmbH
77,700
0.28%
2,500
0.01%
04/30/2018
GO ETF Solutions LLP
64,409
0.24%
64,409
0.01%
02/28/2018
SSgA Funds Management, Inc.
22,700
0.09%
0
0%
09/06/2018
SBI Asset Management Co., Ltd.
6,299
0.02%
6,299
0%
06/05/2017
| Address |
Sumitomo Fudosan Nishi-Shinjuku Bldg
Tokyo Tokyo 151
Japan
|
|
Employees
|
- |
| Website |
http://www.chiome.co.jp |
| Updated |
07/08/2019 |
| Chiome Bioscience, Inc. engages in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) System. Its operations are carried out through Innovative Drug and Innovative Drug Support business segments. The Innovative Drug segment manufactures specific antibodies based on new antigen mechanisms and licenses these out to pharmaceutical industries. |
